Analysts at Wells Fargo downgraded Quest Diagnostics Inc. DGX from Market Perform to Underperform.
Quest Diagnostics shares have gained 35.41% over the past 52 weeks, while the S&P 500 index has surged 13.39% in the same period.
Quest Diagnostics' shares rose 0.74% to close at $71.09 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
